Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangdong Bawei Biotechnology Days Payable?
Guangdong Bawei BiotechnologyBJSE:920123 42 Days Payable is 73.80 as of Mar. 2026, which is 35% above its 10-year median of 54.82. GuruFocus rates BJSE:920123 with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 1,899 Consumer Packaged Goods companies, Guangdong Bawei Biotechnology ranks better than 67.72% on this metric.
The historical rank and industry rank for Guangdong Bawei Biotechnology's Days Payable or its related term are showing as below:
BJSE:920123'
s Days Payable Range Over the Past 10 Years
Min: 22.52 Med: 54.82 Max: 98.86
Current: 63.28
During the past 13 years, Guangdong Bawei Biotechnology's highest Days Payable was 98.86. The lowest was 22.52. And the median was 54.82.
BJSE:920123's Days Payable is ranked better than 67.72% of 1899
companies
in the Consumer Packaged Goods industry
Industry Median: 44.31
vs BJSE:920123: 63.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920123 vs PG, CL, EL: Days Payable Comparison
For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Bawei Biotechnology Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's Days Payable distribution charts can be found below:
* The bar in red indicates where Guangdong Bawei Biotechnology's Days Payable falls into.
Guangdong Bawei Biotechnology Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Bawei Biotechnology (BJSE:920123) has a Days Payable of 73.80 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangdong Bawei Biotechnology and its competitors. This is 35% above median its historical median of 54.82. Over the past decade, Guangdong Bawei Biotechnology's Days Payable has ranged from 22.52 to 98.86. According to the industry distribution chart, Guangdong Bawei Biotechnology ranks #613 out of 1899 companies in the Consumer Packaged Goods industry, placing it in the top 32.3%.
Is Guangdong Bawei Biotechnology's Days Payable too high?
Guangdong Bawei Biotechnology's current Days Payable of 73.80 is 35% above median its 10-year median of 54.82. Over the past 10 years, this metric has ranged from a low of 22.52 to a high of 98.86. The Consumer Packaged Goods industry median Days Payable is 44.31. Guangdong Bawei Biotechnology's value of 73.80 is 66.6% above this industry median. Based on the distribution chart, Guangdong Bawei Biotechnology ranks #613 out of 1899 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Guangdong Bawei Biotechnology has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Bawei Biotechnology's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Bawei Biotechnology ranks #613 out of 1899 companies for Days Payable. This puts Guangdong Bawei Biotechnology in the upper half of its industry. The industry median Days Payable is 44.31. Guangdong Bawei Biotechnology's value of 73.80 is 66.6% above this benchmark. Historically, Guangdong Bawei Biotechnology's own Days Payable has ranged from 22.52 to 98.86 over the past decade. While the company's 10-year median is 54.82 vs. the industry median of 44.31, Guangdong Bawei Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.31, based on 1,899 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Bawei Biotechnology's current Days Payable of 73.80 is 66.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangdong Bawei Biotechnology and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Bawei Biotechnology's current Days Payable is 73.80, which is 35% above median its own 10-year median of 54.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Bawei Biotechnology stock overvalued right now?
Guangdong Bawei Biotechnology (BJSE:920123) has a current Days Payable of 73.80. The current Days Payable is 73.80, which is 35% above median its 10-year median of 54.82 and 66.6% above the Consumer Packaged Goods industry median of 44.31. Guangdong Bawei Biotechnology's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guangdong Bawei Biotechnology (BJSE:920123), the current Days Payable is 73.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920123 has been successfully added to your 
